ELRANATAMAB
UNII L0HR9A577V

Substance Identification & Data

This profile provides standardized clinical and technical data for Elranatamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L0HR9A577V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2408850-14-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L0HR9A577V

CAS Registry Number

2408850-14-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ELRANATAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

L0HR9A577V

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C146860

National Cancer Institute reference terminology for clinical and research data.

INN ID

11838

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-199

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elranatamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELRANATAMAB

ELRANATAMAB-BCMM

Common Names & Synonyms

ANTI-CD3/ANTI-BCMA BISPECIFIC MONOCLONAL ANTIBODY PF-06863135

B-CELL MATURATION ANTIGEN (BCMA) CLUSTER OF DIFFERENTIATION 3 (CD3) BISPECIFIC MONOCLONAL ANTIBODY (MAB) ANTI-BCMA/ANTI-CD3 BISPECIFIC MAB

ELRANATAMAB [INN]

ELRANATAMAB [USAN]

ELRANATAMAB [WHO-DD]

ELRANATAMAB BCMM [WHO-DD]

IMMUNOGLOBULIN G2 (224-ARGININE,265-ALANINE,330-SERINE,331-SERINE), ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-MUS MUSCULUS MONOCLONAL PF-06863059 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PF-06863059 .KAPPA.-CHAIN, (223->217')(227->221')(230->224')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G2 (218-GLUTAMIC ACID,259-ALANINE,324-SERINE,325-SERINE) ANTI-(HUMAN B-CELL MATURATION ANTIGEN) (HUMAN MONOCLONAL PF-06863058 .GAMMA.2-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL PF-06863058 .KAPPA.-CHAIN